閾剁墝浼氬憳绗?span style="font-size:1.5em;color:#f21">2骞滁/div> 璁块棶閲廁 3387222 缃戝潃:antibody.cnreagent.com 鍦ㄧ嚎鐣欒█
浜у搧鎼滅储
鎶椾綋 >> 鍏朵粬鎶椾綋
鐭摼鑴辨阿杩樺師閰?3鎶椾綋
鐭摼鑴辨阿杩樺師閰?3鎶椾綋鍥剧墖
浜よ揣鏈烔 1鍛?/span>
绱㈠彇璧勬枡鍙婃姤浠饵/span>
浜よ揣鏈烔 1鍛?/td>
浜у搧鍒悕: Anti-Dhrs13
Anti-dehydrogenase/reductase (SDR family) member 13 Antibody
浜у搧浠嬬粛
闈舵爣锛欬p style="text-indent: 2em;">Dhrs13


浜у搧鍒悕锛欬p style="text-indent: 2em;">2610209N15Rik锛 Dhrs13锛 dehydrogenase/reductase (SDR family) member 13锛 dehydrogenase/reductase (SDR family) member 13锛 dehydrogenase/reductase SDR family member 13锛 androgen-regulated short-chain dehydrogenase/reductase 1; prostate short-chain dehydrogenase reductase 1; likely ortholog of mouse cell line MC/9.IL4 derived transcript 1; CGI-82 protein; HCV core-binding protein锛 short chain dehydrogenase/reductase family 7C member 5锛 鐭摼鑴辨阿杩樺師閰?3锛


鑳屾櫙淇℃伅锛欬div style="text-indent: 2em;">DHRS13 (dehydrogenase reductase SDR family member 13), also known as UNQ419 PRO853, is a 377 amino acid secreted protein belonging to the short-chain dehydrogenases reductases (SDR) family. DHRS13 is presumed to function as an oxidoreductase and is phosphorylated, potentially by ATM or ATR, upon DNA damage. DHRS13 exists as two isoforms produced by alternative splicing events. The gene encoding DHRS13 maps to human chromosome 17, which comprises over 2.5% of the human genome and encodes over 1,200 genes. Neurofibromatosis, dysregulated Schwann cell growth, Alexander disease, Birt-Hogg-Dube syndrome and Canavan disease are associated with chromosome 17.

瀹夸富锛歊bt
绫诲瀷锛歅ab
鍚岀鍨婜IgG
搴旂敤锛歐B
绾寲鏂瑰紡锛氫翰鍜岀函鍖朁br/>鍋惰仈鐗╋細Unconjugated
鎬х姸锛氭恫浣
瀛樺偍婧舵恫锛氬弬闃呰鏄庝功
娴撳害锛欱atch dependent (Please refer to the vial label for the specific concentration.)
绋€閲婃瘮渚婜 Optimal dilutions/concentrations should be determined by the end user
鍌ㄥ瓨锛氱粡甯镐娇鐢ㄥ垯4掳C淇濆瓨銆?20掳C淇濆瓨涓嶈秴杩囦袱骞淬€傞伩鍏嶅弽澶嶅喕铻嶃€侟br/>娉ㄦ剰浜嬮」锛氫粎渚涘疄楠屽浣跨敤銆備笉閫傜敤浜庝汉绫绘垨鍔ㄧ墿鐨勪换浣曚复搴婏紝娌荤枟鎴栬瘖鏂敤閫斻€備笉閫傚悎鍔ㄧ墿鎴栦汉绫婚鐢ㄣ€侟/p>

鐩稿叧浜у搧
Baidu
map